Clinical Trials Directory

Trials / Conditions / Relapsed/Refractory Large B-cell Lymphoma

Relapsed/Refractory Large B-cell Lymphoma

8 registered clinical trials studyying Relapsed/Refractory Large B-cell Lymphoma — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingLinperlisib Combined With Immunochemotherapy in Relapsed/Refractory LBCL
NCT06489808
Institute of Hematology & Blood Diseases Hospital, ChinaPhase 2
RecruitingMRD-Directed Consolidation With Epcor-only or Epcor-R2 Post Anti-CD19 CAR TCell Therapy for Large B-Cell Lymph
NCT06414148
Peter MacCallum Cancer Centre, AustraliaPhase 2
Active Not RecruitingStudy of KITE-197 in Participants With Relapsed or Refractory Large B-cell Lymphoma
NCT06079164
Kite, A Gilead CompanyPhase 1
TerminatedEvaluation of Lymphodepletion With ALLO-647 in Adults With R/R Large B Cell Lymphoma Receiving ALLO-501A Allog
NCT05714345
Allogene TherapeuticsPhase 2
RecruitingA Study of C-CAR039 (Prizloncabtagene Autoleucel) in Patients With Relapsed/Refractory Large B-Cell Lymphoma
NCT05800977
Shanghai AbelZeta Ltd.Phase 1 / Phase 2
TerminatedStudy of Lenzilumab and Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymph
NCT04314843
Kite, A Gilead CompanyPhase 1
CompletedSafety and Efficacy of ALLO-501 Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Ce
NCT03939026
Allogene TherapeuticsPhase 1
TerminatedSafety and Efficacy of Axicabtagene Ciloleucel in Combination With Utomilumab in Adults With Refractory Large
NCT03704298
Kite, A Gilead CompanyPhase 1